JP2023524911A5 - - Google Patents

Info

Publication number
JP2023524911A5
JP2023524911A5 JP2023509461A JP2023509461A JP2023524911A5 JP 2023524911 A5 JP2023524911 A5 JP 2023524911A5 JP 2023509461 A JP2023509461 A JP 2023509461A JP 2023509461 A JP2023509461 A JP 2023509461A JP 2023524911 A5 JP2023524911 A5 JP 2023524911A5
Authority
JP
Japan
Application number
JP2023509461A
Other languages
Japanese (ja)
Other versions
JPWO2021216891A5 (https=
JP2023524911A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/028667 external-priority patent/WO2021216891A2/en
Publication of JP2023524911A publication Critical patent/JP2023524911A/ja
Publication of JP2023524911A5 publication Critical patent/JP2023524911A5/ja
Publication of JPWO2021216891A5 publication Critical patent/JPWO2021216891A5/ja
Pending legal-status Critical Current

Links

JP2023509461A 2020-04-24 2021-04-22 Sars-cov-2抗ウイルス薬としての脂質-ペプチド融合物阻害剤 Pending JP2023524911A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063015479P 2020-04-24 2020-04-24
US63/015,479 2020-04-24
PCT/US2021/028667 WO2021216891A2 (en) 2020-04-24 2021-04-22 Lipid-peptide fusion inhibitors as sars-cov-2 antivirals

Publications (3)

Publication Number Publication Date
JP2023524911A JP2023524911A (ja) 2023-06-13
JP2023524911A5 true JP2023524911A5 (https=) 2024-05-07
JPWO2021216891A5 JPWO2021216891A5 (https=) 2024-05-07

Family

ID=78270019

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023509461A Pending JP2023524911A (ja) 2020-04-24 2021-04-22 Sars-cov-2抗ウイルス薬としての脂質-ペプチド融合物阻害剤

Country Status (9)

Country Link
US (1) US20230159597A1 (https=)
EP (1) EP4139330A4 (https=)
JP (1) JP2023524911A (https=)
KR (1) KR20230028719A (https=)
CN (1) CN115916806A (https=)
BR (1) BR112022021528A2 (https=)
CA (1) CA3175831A1 (https=)
IL (1) IL297498A (https=)
WO (1) WO2021216891A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3235784A1 (en) * 2021-10-22 2023-04-27 Wisconsin Alumni Research Foundation Peptides that inhibit infection by sars-cov-2, the virus that causes covid-19 disease
WO2024016011A2 (en) * 2022-07-15 2024-01-18 The Trustees Of Columbia University In The City Of New York Broad spectrum inhibition of human coronaviruses by lipopeptides derived from the c-terminal heptad repeat of betacoronaviruses
WO2025231157A2 (en) * 2024-04-30 2025-11-06 Decoy Therapeutics Inc. New anti-viral therapeutic peptides, conjugates, and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032453A2 (en) * 2003-04-28 2005-04-14 Sequoia Pharmaceuticals, Inc. Antiviral agents for the treatment, control and prevention of infections by coronaviruses
US20080027006A1 (en) * 2004-02-12 2008-01-31 The Regents Of The University Of Colorado Compositions And Methods For Modification And Prevention Of Sars Coronavirus Infectivity
GB0720503D0 (en) * 2007-10-22 2007-11-28 Angeletti P Ist Richerche Bio New compound
WO2010089129A1 (en) * 2009-02-06 2010-08-12 Cormus Srl Inhibitors of viral fusion and uses thereof
WO2012020108A2 (en) * 2010-08-11 2012-02-16 Cormus Srl Multimeric inhibitors of viral fusion and uses thereof
CN104151403B (zh) * 2013-04-08 2020-11-03 中国医学科学院药物研究所 一类多肽或其衍生物、及其在流感病毒感染中的应用
US10172961B2 (en) * 2014-05-07 2019-01-08 Cornell University Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them
WO2017015457A1 (en) * 2015-07-21 2017-01-26 Modernatx, Inc. Ebola vaccine
US20180243225A1 (en) * 2017-01-25 2018-08-30 Modernatx, Inc. Ebola/marburg vaccines
CA3173973A1 (en) * 2020-03-04 2021-09-10 Dana-Farber Cancer Institute, Inc. Antiviral structurally-stabilized sars-cov-2 peptides and uses thereof

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JP2023524911A5 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021016200A2 (https=)
BR102021015450A8 (https=)
BR102021015220A2 (https=)
BR102021015247A2 (https=)
BR102021014044A2 (https=)
BR102021013929A2 (https=)
BR102021012571A2 (https=)